OneTouch Select Plus Simple®

The OneTouch Select Plus Simple® blood glucose monitoring system is designed for self-monitoring outside the human body (in vitro diagnostic use). It can be used by people with diabetes at home and with their healthcare professionals in a healthcare setting as an aid to monitoring the effectiveness of diabetes control. The system is intended for use by one patient only and should not be shared with other persons.

The OneTouch Select Plus Simple® Blood Glucose Monitoring System is not intended for the diagnosis or screening of diabetes mellitus or for the measurement of blood glucose in newborns.

The OneTouch Select Plus Simple® Blood Glucose Monitoring System is not intended for use in critically ill, shocked, severely dehydrated, or hyperosmolar patients.

Principle of testing

The glucose in the blood sample is mixed with the test strip enzyme, glucose oxidase, to produce a small electric current. The strength of this current varies depending on the level (concentration) of glucose in the blood sample. Your blood glucose meter measures the current, calculates your blood glucose level, displays this result on the screen, and stores it in memory.

The OneTouch Select Plus Simple® Blood Glucose Monitoring System includes:

• OneTouch Select Plus Simple® Blood Glucose Monitor with CR2032 flat-cell lithium battery included Injection
• pen OneTouch® Delica® Plus
• Lancets OneTouch® Delica® Plus Lancets - 10 sterile lancets
• Instructions for use in Ukrainian.

Sold separately: OneTouch Select® Plus Test Strips, OneTouch® Delica® Plus Lancets. For the Control Solution OneTouch Select® Plus, please contact the Lifescan Consultation Line at: 0 800 500 353 (free of charge in Ukraine), Monday-Friday, 09:00-18:00. 

LifeScan Europe GmbH, Gubelstrasse 34, CH-6300 Zug, Switzerland.

Authorized representative of the manufacturer in Ukraine:

Universal Agency Pro-Pharma LLC, 9 Peremohy St., office 20, Kyiv, 3170, Ukraine.

(1)Grady M, Lamps G, Shemain A, Cameron H, Murray L. Clinical Evaluation of a New, Lower Pain, One Touch Lancing Device for People With Diabetes: Virtually Pain-Free Testing and Improved Comfort Compared to Current Lancing Systems. Journal of Diabetes Science and Technology. 2021;15(1):53-59. doi:10.1177/1932296819856665

(2) Internal data of LifeScan Scotland Ltd. Select Plus 5 Year Clinical Accuracy Assessment. Document FILE-REP-0086067. EN ISO 15197:2015 In vitro diagnostic medical device - Requirements for medical devices for measuring blood glucose levels for self-testing in diabetes mellitus (ISO 15197:2013)Accuracy is ensured within the limits stated in the instructions for use for the relevant Blood Glucose Monitoring System, provided that the test rules are followed according to the instructions for use for the Blood Glucose Monitoring System and the relevant test strips.